Melatonin's Effectiveness Remains Murky
New evidence released by the Agencyfor Healthcare Research and Quality(AHRQ) concluded that melatonin does notwork in treating a majority of primary sleepdisorders.
The federal agency said that melatoninsupplements do not appear to affect sleepquality, wakefulness after sleep onset, totalsleep time, or percentage of the time spentin rapid eye movement sleep. All are key criteriafor an effective treatment for sleepproblems such as insomnia.
AHRQ's review suggested that melatoninin oral doses are relatively safe when takenfor the short term, over a period of days orweeks, and is safe at relatively high dosesand in various formulations. The agency,however, said the safety of melatonin supplementationwhen used for the long termremains unclear.
Articles in this issue
Newsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.
Related Articles
- Advise Patients About Self-Care Measures to Treat Mild to Moderate GI Issues
September 18th 2025
- Evaluation of Pharmacist-Driven Penicillin Allergy Reconciliation
September 17th 2025
- Pharmacists Can Apply Their Expertise to the Medical Psilocybin Act
September 16th 2025
- From Curiosity to Clinical Impact: Shremo Msdi’s Path in Pharmacy Research
September 15th 2025